Cargando…

Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies

The prevalence of Helicobacter pylori infection remains significant worldwide and it depends on many factors: gender, age, socio-economic status, geographic area, diet, and lifestyle. All successful infectious diseases treatments use antibiotic-susceptibility testing, but this strategy is not curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardos, Ioana Alexandra, Zaha, Dana Carmen, Sindhu, Rakesh K., Cavalu, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512130/
https://www.ncbi.nlm.nih.gov/pubmed/34641620
http://dx.doi.org/10.3390/molecules26196078
_version_ 1784582916828823552
author Cardos, Ioana Alexandra
Zaha, Dana Carmen
Sindhu, Rakesh K.
Cavalu, Simona
author_facet Cardos, Ioana Alexandra
Zaha, Dana Carmen
Sindhu, Rakesh K.
Cavalu, Simona
author_sort Cardos, Ioana Alexandra
collection PubMed
description The prevalence of Helicobacter pylori infection remains significant worldwide and it depends on many factors: gender, age, socio-economic status, geographic area, diet, and lifestyle. All successful infectious diseases treatments use antibiotic-susceptibility testing, but this strategy is not currently practical for H. pylori and the usual cure rates of H. pylori are lower than other bacterial infections. Actually, there is no treatment that ensures complete eradication of this pathogen. In the context of an alarming increase in resistance to antibiotics (especially to clarithromycin and metronidazole), alternative and complementary options and strategies are taken into consideration. As the success of antibacterial therapy depends not only on the susceptibility to given drugs, but also on the specific doses, formulations, use of adjuvants, treatment duration, and reinfection rates, this review discusses the current therapies for H. pylori treatment along with their advantages and limitations. As an alternative option, this work offers an extensively referenced approach on natural medicines against H. pylori, including the significance of nanotechnology in developing new strategies for treatment of H. pylori infection.
format Online
Article
Text
id pubmed-8512130
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85121302021-10-14 Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies Cardos, Ioana Alexandra Zaha, Dana Carmen Sindhu, Rakesh K. Cavalu, Simona Molecules Review The prevalence of Helicobacter pylori infection remains significant worldwide and it depends on many factors: gender, age, socio-economic status, geographic area, diet, and lifestyle. All successful infectious diseases treatments use antibiotic-susceptibility testing, but this strategy is not currently practical for H. pylori and the usual cure rates of H. pylori are lower than other bacterial infections. Actually, there is no treatment that ensures complete eradication of this pathogen. In the context of an alarming increase in resistance to antibiotics (especially to clarithromycin and metronidazole), alternative and complementary options and strategies are taken into consideration. As the success of antibacterial therapy depends not only on the susceptibility to given drugs, but also on the specific doses, formulations, use of adjuvants, treatment duration, and reinfection rates, this review discusses the current therapies for H. pylori treatment along with their advantages and limitations. As an alternative option, this work offers an extensively referenced approach on natural medicines against H. pylori, including the significance of nanotechnology in developing new strategies for treatment of H. pylori infection. MDPI 2021-10-08 /pmc/articles/PMC8512130/ /pubmed/34641620 http://dx.doi.org/10.3390/molecules26196078 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cardos, Ioana Alexandra
Zaha, Dana Carmen
Sindhu, Rakesh K.
Cavalu, Simona
Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies
title Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies
title_full Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies
title_fullStr Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies
title_full_unstemmed Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies
title_short Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies
title_sort revisiting therapeutic strategies for h. pylori treatment in the context of antibiotic resistance: focus on alternative and complementary therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512130/
https://www.ncbi.nlm.nih.gov/pubmed/34641620
http://dx.doi.org/10.3390/molecules26196078
work_keys_str_mv AT cardosioanaalexandra revisitingtherapeuticstrategiesforhpyloritreatmentinthecontextofantibioticresistancefocusonalternativeandcomplementarytherapies
AT zahadanacarmen revisitingtherapeuticstrategiesforhpyloritreatmentinthecontextofantibioticresistancefocusonalternativeandcomplementarytherapies
AT sindhurakeshk revisitingtherapeuticstrategiesforhpyloritreatmentinthecontextofantibioticresistancefocusonalternativeandcomplementarytherapies
AT cavalusimona revisitingtherapeuticstrategiesforhpyloritreatmentinthecontextofantibioticresistancefocusonalternativeandcomplementarytherapies